Yet for all China's economic heft, the yuan remains a featherweight, accounting for around 2 percent of foreign reserves in ...

Matthew Sun, Jericho Bautista, Sam Kakria, and Andy Huang wait for their friends outside of Trader Joe’s in Hayes Valley, San Francisco. Those who attended the matchmaking event at Trader Joe’s were ...

The Odisha State Pollution Control Board has issued a set of comprehensive guidelines prohibiting the use of single-use ...

Drug observers puzzled by vaccine maker, which made a killing on COVID-19, failing to read the room with new administration. Moderna puts heat on FDA vaccines chief who's already been rebuked once by ...

The year ahead will show whether Fiji’s political old guard can cede to a new generation, or if it will merely continue ...

Tech stocks took it on the chin on Thursday, with the Nasdaq Composite dropping 2% following disappointing earnings from Cisco Systems. Apple also recorded a 5% drop yesterday, its biggest since the ...

From the latest Hindi series Bandwaale to Telugu film Mana Shankara Vara Prasad Garu, here’s a look at the new OTT releases to watch in Indian ...

The anti-science, anti-medicine mindset of the nutso Health and Human Services Secretary Robert F. Kennedy Jr. is killing people by quashing life-saving vaccines.

The post Clinical Trials Show Moderna's New mRNA Flu Vaccine Is Safe and Effective. FDA Won't Even Consider It. appeared ...

At issue with Moderna's mRNA flu shot is communication from CBER to Moderna suggesting that the company’s vaccine be compared ...

Moderna’s mRNA-1010 was expected to contribute $1 billion to the company’s coffers by 2028. That plan is now out the window after the FDA refused to even look at the application.

Senior FDA official Vinay Prasad reportedly overrode his staff in deciding to reject Moderna's application for a new seasonal flu shot.